Patrys Limited (PAB.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEDT
| Previous close | 0.0240 |
| Open | 0.0250 |
| Bid | 0.0240 x 166154000 |
| Ask | 0.0250 x 165000000 |
| Day's range | 0.0240 - 0.0250 |
| 52-week range | 0.0180 - 0.0340 |
| Volume | |
| Avg. volume | 3,375,912 |
| Market cap | 51.432M |
| Beta (5Y monthly) | 0.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy
MELBOURNE, Australia, November 18, 2022--Patrys Limited (ASX: PAB, "Patrys" or the "Company"), a therapeutic antibody development company, has announced the appointment of Dr. Charmaine Gittleson as the Chairman of the Board of Directors – a highly respected and experienced global biotechnology leader.
© 2023 Yahoo. All rights reserved.
